Delivery Order SPE2DB24D2208-SPE2DB24FHHFF

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $7.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a $1,900.08 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565177698 ELIQUIS 2.5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $2,065.21 firm fixed price delivery order contract (SPE2DX15D3504|SPE2DX24F05K0) for the supply of ELIQUIS 5 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to provide pharmaceutical products...
The U.S. Defense Logistics Agency (DLA) awarded a $17,980.34 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,599.60 firm fixed price delivery order contract to provide ELIQUIS 5 MG TABLET 60S. This order falls under a larger, single-award, indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceutical products and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $33,787.43 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period through April 11, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) worth up to $999,999,999.00 that AmerisourceBergen Drug...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract, valued at $33,195.28, to Amerisourcebergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
The U.S. Defense Logistics Agency (DLA) awarded a $3,074.77 delivery order contract to Amerisourcebergen Drug Corp for the supply of ELIQUIS 5 MG TABLET 60S. The contract has a firm fixed price and an ultimate completion date of September 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with DLA Troop Support Medical for delivering a wide range of medical commodities to support military treatment programs....
The U.S. Defense Logistics Agency (DLA) awarded a $3,851.90 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4567732654 ELIQUIS 5 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, to provide 4556873913 ELIQUIS 5 MG TABLET 60S. The contract has a potential value of $6,478.45 and a period of performance through April 13, 2022. This delivery order is issued under Amerisourcebergen Drug Corp's single-award indefinite delivery contract with...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ELIQUIS 5 MG TABLET 60S. This $13,208.01 order, which has a completion date of February 8, 2024, is part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB24FHHFF
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $7,807.53 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of 4565767348 ELIQUIS 5 MG TABLET 60S. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by September 12, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain network to provide essential medications, over-the-counter drugs, and medical supplies to various defense and civilian agencies.

Generated 12/11/24, 9:38 AM